Literature DB >> 6607733

A long-term longitudinal study of anticentromere antibodies.

H D Tramposch, C D Smith, J L Senecal, N Rothfield.   

Abstract

A longitudinal retrospective study of 37 patients previously tested for anticentromere antibodies (ACA) in 1982 was carried out. No ACA were found in stored sera from 22 ACA-negative patients including 1 patient with CREST (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia). All ACA-positive patients, with 1 exception, were found to have ACA in their sera over prolonged periods of time. One patient developed ACA for the first time when the third feature of the CREST syndrome (Raynaud's phenomenon) was noted. Anticentromere antibodies were IgG, and no consistent change in titer over time was found.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607733     DOI: 10.1002/art.1780270201

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

Review 1.  Anti-centromere antibodies (ACA).

Authors:  C G Kallenberg
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 2.  Utility of serologic testing in the diagnosis of noninfectious pulmonary disorders.

Authors:  R H White; J A Golden
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

Review 3.  Biomarkers in the management of scleroderma: an update.

Authors:  Giuseppina Abignano; Maya Buch; Paul Emery; Francesco Del Galdo
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

4.  Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma.

Authors:  A C Gelber; S R Pillemer; B J Baum; F M Wigley; L K Hummers; S Morris; A Rosen; L Casciola-Rosen
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

5.  Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.

Authors:  L Kremer; J M Alvaro-Gracia; C Ossorio; J Avila
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

6.  Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma.

Authors:  W C Earnshaw; N Rothfield
Journal:  Chromosoma       Date:  1985       Impact factor: 4.316

7.  Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.

Authors:  W Earnshaw; B Bordwell; C Marino; N Rothfield
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

Review 8.  Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex.

Authors:  C G Kallenberg
Journal:  Clin Rev Allergy       Date:  1994

9.  Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study.

Authors:  N J McHugh; J Whyte; C Artlett; D C Briggs; C O Stephens; N J Olsen; N G Gusseva; P J Maddison; C M Black; K Welsh
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

10.  Anticentromere-protein-B--DNA complex activities in anticentromere antibody-positive patients.

Authors:  Y Muro; Y Matsumoto; M Ohashi
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.